Abstract
Cancer is awful disease, which makes panicle network in the body system of patients. Cancer is characterized by abnormal and uncontrolled cell growth, which results in the formation of lumps or masses in body known as tumor. There are more than 100 types of cancers and each is classified according to the cell capacity and size. Globally, cancer is accepted as the second leading cause of death. As per a WHO report, cancer is responsible for 8.8 million deaths in 2015. Anti-cancer drugs or oncology medicines are employed in taking the care of different patients. At the present time, many pharmaceutical companies are active in producing oncology medicines. It is probed that by pharmaceutical scientists how cancer treatments under the scheduled time can save life of patients and a delay in treating cancer patients may have unseemly effects on the life of patients. The presented research focuses on two cases. The first was conducted at Jabalpur Hospital & Research Centre (JHRC), where a structure/model related to A-CMsP company is built for assessing the performance under chain of sustainable procurement criteria. The second research focuses on the benchmarking of two A-CMsP companies. A multi objective optimization approach is implemented, accompanied with vague modeling for computing the overall performance index of oncology medicines.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Social Ecology and Sustainable Development
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
